Live Breaking News & Updates on Isadora Forman

Stay updated with breaking news from Isadora forman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wesana Announces First Quarter 2022 Financial Results

Wesana Announces First Quarter 2022 Financial Results
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United States , Isadora Forman , Daniel Carcillo , Wesana Solutions , Wesana Health , Company Board , Wesana Health Holdings Inc , Drug Administration , Company The Board , Canadian Securities Exchange , Investigational New Drug , Animal Study , Wesana Clinic , Care Delivery , Diluted Shares Outstanding , Proportionate Subordinate Voting Shares , Super Voting Shares , Subordinate Voting Shares , Findings Indicating Psilocybin Potentiates Impact , Traumatic Brain Injury , Tech Connect , Chad Bronstein , Executive Chairman ,

Wesana Is Exploring Broadening SANA-013 Lead Indication to

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED. ....

United States , Mark Wingertzahn , Isadora Forman , Daniel Carcillo , World Health Organization , Drug Administration , Wesana Health Holdings Inc , Company The Board , Wesana Health , Emergen Research , Canadian Securities Exchange , Voting Share Of The Company , Health Holdings Inc , United States Food , Major Depressive Disorder , Chief Executive Officer , Chief Scientific Officer , Subordinate Voting Share Units , Multiple Voting Share Units , Subordinate Voting Share , Multiple Voting Share , Canadian Securities , United States Securities Act , Canadian Stock Exchange Wesa , Wesana Health ,

Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

29.03.2022 - CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) - Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new . ....

United States , Isadora Forman , Investor Relations Corporate Development At Wesana , Wesana Health , Psychedelic Therapeutics Drug Development Conference , Benzinga Psychedelics Capital Conference , Capital Market Noblecon , Psychedelic Therapeutics , Drug Development Conference , Keenan Gentry , Vice President Investor Relations , Corporate Development ,